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OBJECTIVE—Natriuretic peptides (NPs) have been character-
ized as vascular hormones that regulate vascular tone via guany-
lyl cyclase (GC), cyclic GMP (cGMP), and cGMP-dependent
protein kinase (cGK). Recent clinical studies have shown that
plasma NP levels were lower in subjects with the metabolic
syndrome. The present study was conducted to elucidate the
roles for NP/cGK cascades in energy metabolism.
RESEARCH DESIGN AND METHODS—We used three types
of genetically engineered mice: brain NP (BNP) transgenic
(BNP-Tg), cGK-Tg, and guanylyl cyclase-A (GCA) heterozygous
knockout (GCA
/) mice and analyzed the metabolic conse-
quences of chronic activation of NP/cGK cascades in vivo. We
also examined the effect of NPs in cultured myocytes.
RESULTS—BNP-Tg mice fed on high-fat diet were protected
against diet-induced obesity and insulin resistance, and cGK-Tg
mice had reduced body weight even on standard diet; surpris-
ingly, giant mitochondria were densely packed in the skeletal
muscle. Both mice showed an increase in muscle mitochondrial
content and fat oxidation through upregulation of peroxisome
proliferator–activated receptor (PPAR)- coactivator (PGC)-1
and PPAR. The functional NP receptors, GCA and guanylyl
cyclase-B, were downregulated by feeding a high-fat diet, while
GCA
/ mice showed increases in body weight and glucose
intolerance when fed a high-fat diet. NPs directly increased the
expression of PGC-1 and PPAR and mitochondrial content in
cultured myocytes.
CONCLUSIONS—The ﬁndings together suggest that NP/cGK
cascades can promote muscle mitochondrial biogenesis and
fat oxidation, as to prevent obesity and glucose intolerance.
The vascular hormone, NP, would contribute to coordinated
regulation of oxygen supply and consumption. Diabetes 58:
2880–2892, 2009
N
atriuretic peptides (NPs), consisting of atrial,
brain, and C-type NPs (ANP, BNP, and CNP,
respectively), have been characterized as car-
diac or vascular hormones that reduce vascular
tone and circulating blood volume (1). NPs can stimulate
at least two types of biologically active receptors, guanylyl
cyclase-A (GCA) and guanylyl cyclase-B (GCB), which act
as membrane-bound GCs to synthesis intracellular cGMP.
NPs exert their biological effects through GC-mediated
synthesis of cyclic GMP (cGMP) and subsequent activa-
tion of cGMP-dependent protein kinase (cGK)-I, which
constitute the common signal transduction pathway for
nitric oxide (NO). On the other hand, type C NP receptor
(C-receptor) is indicated as having a role as a clearance
receptor, which binds and incorporates NPs into cyto-
plasm and inactivates them.
We and others (2) have demonstrated that the intrave-
nous infusion of ANP or BNP into patients with heart
failure reduces cardiac pre- and post-load and results in
beneﬁcial hemodynamic function; therefore, they are
widely used for the treatment of congestive heart failure.
Recently, we have elucidated new roles for NPs in the
promotion of neovascularization in ischemic tissues and
introduced a therapeutic application of NPs for patients
with peripheral artery occlusive diseases (3,4). Meanwhile,
CNP is shown to stimulate endochondral bone formation
through GCB-dependent signal pathways, and its thera-
peutic application to human achondroplasia is expected
(5).
In these ways, the cardiac hormones, NPs, have been
indicated to act on the cardiovascular and cartilage-bone
systems. Recent reports have suggested that NPs may also
affect cultured human adipocytes and exert lipolytic ac-
tion (6), which is associated with cGK-mediated activation
of hormone-sensitive lipase (HSL) (7). In addition, obese
individuals in the cohorts of the Framingham Heart Study
were found to hold considerably lower plasma NP levels
than those with normal weight (8). Lower plasma NP
levels were also associated with the development of
insulin resistance and metabolic syndrome, even after
adjustment for BMI (9). These ﬁndings indicate that the
activation of NP/cGK cascades can regulate lipid metabo-
lism in humans to reduce susceptibility to obesity and the
metabolic syndrome.
In a previous report (10), we have shown that cGMP can
regulate mitochondrial content and function in C2C12
myotubular cells by altering the expressions of genes
involved in mitochondrial biogenesis and reactive oxygen
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three types of genetically engineered mice to elucidate the
metabolic consequences of chronic activation of NP/cGK
cascades in vivo. One type is BNP transgenic mice (BNP-
Tg) with serum amyloid P (SAP) promoter, which overex-
press BNP speciﬁcally in the liver and have BNP plasma
levels 100 times higher than the physiological condition
(11). The other two types are cGK transgenic mice (cGK-
Tg) with a chicken -actin promoter combined with cyto-
megalovirus immediate-early enhancers (CAG promoter),
which overexpress human cGK-I ubiquitously (3), and
GCA heterozygous knockout (GCA
/) mice (12). The
ﬁndings of the present study demonstrate signiﬁcant roles
for NP/cGK cascades in mitochondrial biogenesis, fat
oxidation, and oxygen consumption, indicating that an
activation of the cascades would be therapeutically bene-
ﬁcial for the treatment of obesity, insulin resistance, fatty
liver, and the metabolic syndrome.
RESEARCH DESIGN AND METHODS
RESEARCH DESIGN AND METHODS are shown in supplement 1 in the online appendix
(13–16) (available at http://diabetes.diabetesjournals.org/cgi/content/full/db09-
0393/DC1).
RESULTS
BNP-Tg mice attenuate diet-induced obesity and in-
sulin resistance. To examine the effects of NPs on body
weight and on glucose and lipid metabolism, BNP-Tg mice
were given a high-fat (60 kcal% fat) diet. The body weight
of BNP-Tg mice on standard diet tended to decrease
compared with that of their littermate wild-type mice
(4.8% reduction at 18 weeks old, n  18 per group, P 
0.06) (Fig. 1A). When fed a high-fat diet from the age of 10
weeks, on the other hand, the weight of the BNP-Tg mice
at 18 weeks old was signiﬁcantly lower than that of the
wild-type controls (38.9  1.0 g for the former and 43.0 
0.9 g for the latter; n  10, P 	 0.01) (Fig. 1A). The
reduction in body weight of the transgenic mice fed a high-fat
diet could be macroscopically observed (Fig. 1B). Food
intake (kcal/day) was not signiﬁcantly different between
BNP-Tg and wild-type mice whether on standard or high-fat
diet, despite the difference in body weight (Fig. 1C).
The blood glucose and insulin levels were identical for
BNP-Tg and wild-type mice on standard diet, both during
ad libitum feeding and fasting. However, these levels were
signiﬁcantly lower in BNP-Tg mice during ad libitum
feeding of the high-fat diet (Table 1). Blood glucose levels
were also lower in BNP-Tg mice fed a high-fat diet after
administration of glucose or insulin (Fig. 1D). On the other
hand, serum triglyceride and fatty acid levels did not show
any signiﬁcant differences between the two groups, both
when feeding ad libitum and fasting (Table 1). The greater
increase in the serum fatty acid level after 24-h fasting was
observed in BNP-Tg mice (Table 1). Urinary excretion of
catecholamines (epinephrine and norepinephrine) was
similar between the two groups (Table 1).
To estimate the fat weight in mice, we used computed
tomography (CT) and scanned the whole body of mice.
The high-fat diet produced a substantial increase in the
adipose tissue in both the subcutaneous and visceral area.
The total fat weight of BNP-Tg mice fed on a high-fat diet
was signiﬁcantly lower (26% reduction, n  6, P 	 0.01)
(Fig. 1E) than that of wild-type mice. The relative reduc-
tion ratio was similar for both subcutaneous and visceral
fat (21% reduction for subcutaneous and 29% for visceral
fat). The high-fat–fed BNP-Tg mice had less surgically
harvested epididymal and visceral fats than the wild-type
mice (Fig. 1F), which is a compatible ﬁnding with the
CT-based fat quantiﬁcation. On the other hand, lean body
mass showed no signiﬁcant difference (26.6  1 . 3gi n
BNP-Tg mice fed a high-fat diet and 27.2  1 . 2gi n
wild-type mice).
To further study the effects of NPs on diet-induced lipid
accumulation, we examined adipose tissue, liver, and
skeletal muscle of BNP-Tg mice fed a high-fat diet for a
comparison with those of wild-type mice. We found that
the histologically examined adipocytes in the epididymal
fat were smaller in BNP-Tg mice (Fig. 1G). In support of
this ﬁnding, serum leptin was found to decrease and
adiponectin to increase in BNP-Tg mice fed a high-fat diet
(Fig. 1H). The liver of wild-type mice had a whitish
appearance, while that of high-fat–fed BNP-Tg mice was
reddish and lower in weight (1.4  0.1 g in high-fat–fed
BNP-Tg mice and 1.7  0.1 g in wild-type mice, n  6,
P 	 0.05) (Fig. 1I). Oil red O staining and triglyceride
measurements of the liver conﬁrmed that diet-induced
lipid accumulation was signiﬁcantly attenuated in high-
fat–fed BNP-Tg mice (30% decrease in triglyceride con-
centration, P 	 0.05, n  12) (Fig. 1J), and a similar
attenuation of lipid accumulation was observed in the
skeletal muscle (27% reduction, n  12, P 	 0.05) (Fig.
1K). These ﬁndings indicate that diet-induced ectopic fat
accumulation was reduced in BNP-Tg mice in addition to
the reduction in adipose tissue.
High-fat–fed BNP-Tg mice exhibit higher oxygen con-
sumption and fat oxidation. The respiratory gas analysis
demonstrated that BNP-Tg mice on a high-fat diet consumed
more oxygen than wild-type mice (n  6, P 	 0.01) (Fig. 2A).
Mean oxygen consumption for 24 h of BNP-Tg mice on
standard diet was 64.3  0.9 ml  min
1  kg body wt
1, and
that of wild-type mice was 62.6  0.9 ml  min
1  kg body
wt
1. The value of wild-type mice on high-fat diet decreased
to 51.8  0.7 ml  min
1  kg body wt
1, and that of BNP-Tg
was 58.7  0.5 ml  min
1  kg body wt
1. The value was
signiﬁcantly higher than that of wild-type mice (n  6, P 	
0.01) (Fig. 2B). The rectal temperature was similar between
BNP-Tg and wild-type mice, whether on standard diet or
high-fat diet (Fig. 2C). The respiratory quotient showed a
signiﬁcant reduction in high-fat–fed BNP-Tg mice, especially
during the daytime (Fig. 2D). The mean respiratory quotient
for 24 h of high-fat–fed BNP-Tg mice was 0.80  0.02, and
that of wild-type mice was 0.81  0.01 (n  6, P 	 0.05). In
line with the reduction in respiratory quotient, mean fat
oxidation for 24 h of high-fat–fed BNP-Tg mice, estimated
from the results of the respiratory gas analysis, was in-
creased to 18.5  0.2 ml  min
1  kg body wt
1, while that of
wild-type mice was 16.8  0.2 ml  min
1  kg body wt
1 (n 
6, P	0.01) (Fig. 2E). The increase in fat oxidation in BNP-Tg
mice could be augmented by fasting (Fig. 2F).
To further investigate the mechanism for the increase in
oxygen consumption of high-fat–fed BNP-Tg mice, we
checked mitochondrial DNA copy number in the brown
adipose tissue and skeletal muscle, which are the major sites
for energy expenditure. Quantitative PCR analysis demon-
strated a signiﬁcant increase in the mitochondrial DNA copy
number in the skeletal muscle of high-fat–fed BNP-Tg mice
(Fig. 2G); however, the increase in the brown adipose tissue
was weak (Fig. 2G), in accordance with unchanged rectal
temperature (Fig. 2C). In conjunction with these ﬁndings, the
expressions of the genes encoding peroxisome proliferator–
activated receptor (PPAR)- coactivator (PGC)-1 and un-
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FIG. 1. BNP-Tg mice are protected against diet-induced obesity and insulin resistance. Wild-type and BNP-Tg mice were given high-fat (60 kcal%
fat) diet from the age of 10 weeks. A: Body weight of the BNP-Tg mice on standard diet (left panel) and a high-fat diet (right panel)( n  18 per
group on standard diet and n  10 on high-fat diet). u, wild type; f, BNT-Tg. B: Macroscopic appearance of a wild-type (Wt) and a BNP-Tg mouse
fed on high-fat diet at 18 weeks of age. C: Food intake on standard diet and high-fat diet (n  6). D: Blood glucose levels determined with the
glucose and insulin tolerance tests (n  8). u, wild type; f, BNT-Tg. E: CT images obtained at kidney level of a wild-type (Wt) and a BNP-Tg mouse
on standard diet (upper panel) and high-fat diet (lower panel). Subcutaneous fat (yellow), abdominal fat (red), and muscular region (blue) were
distinguished. Total fat weight was estimated from the images (n  6). F: Macroscopic appearances and weights of epididymal fat (upper panel)
and mesenteric fat (lower panel). G: Microscopic analysis with hematoxylin and eosin staining of epididymal fat in high-fat–fed mice (left panels).
Scale bar, 100 m. Adipocyte size of epididymal fat in high-fat–fed mice was estimated from the histological analysis (right panel)( n  8). H:
Serum leptin and adiponectin levels (n  8). I: Macroscopic appearance of the liver of the mice fed on high-fat diet (upper panel). Microscopic
images of the liver stained with Oil red O (lower panel). Scale bar, 100 m. J and K: Triglyceride concentrations in the liver (J) and the
quadriceps (K)( n  12). *P < 0.05; **P < 0.01 vs. wild-type (Wt) mice on the same feeding condition. (A high-quality color digital representation
of this ﬁgure is available in the online issue.)
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mitochondrial biogenesis and thermogenesis, respectively,
were not signiﬁcantly upregulated in the brown adipose
tissue of the Tg mice (Fig. 2H); whereas in the skeletal
muscle, the expressions of the genes encoding PGC-1 and
PPAR, which are known to participate in fat oxidation and
energy expenditure, were upregulated in high-fat–fed BNP-Tg
mice (Fig. 2H).
The expressions of NP receptors are regulated by
feeding condition, and GCA knockdown mice are
susceptible to diet-induced obesity and glucose intol-
erance. The results of the study shown in Fig. 3 are
described in supplement 2 in the online appendix.
cGK-Tg mice are lean and insulin sensitive even on
standard diet. To determine the effect of cGK-I, a major
downstream effector of NP/GC/cGMP cascades, on body
weight and on glucose and lipid metabolism, we examined
the cGK-Tg mice with ubiquitously overexpressing human
cGK-I. The cGK-Tg mice showed a signiﬁcant reduction in
body weight compared with wild-type mice, even on
standard diet (27.6  0.4 g for cGK-Tg and 32.0  0.6 g for
wild-type mice, at 18 weeks old on standard diet, n  8,
P 	 0.01) (Fig. 4A). Moreover, high-fat diet–induced
weight gain was attenuated in the Tg mice, and the
reduction in body weight eventually reached 
20%. At 18
weeks of age, their body weight was 35.7  0.4 g, and that
of wild-type mice was 43.9  0.6 g (after 8 weeks of
high-fat feeding, n  8, P 	 0.01) (Fig. 4A and B). The daily
food intake (kcal/day) was not noticeably different for
cGK-Tg and wild-type mice, while it showed a signiﬁcant
increase in cGK-Tg mice when it was adjusted for body
weight (kcal  day
1  g body wt
1) (Fig. 4C).
The blood glucose levels were signiﬁcantly lower in
cGK-Tg mice, both during ad libitum feeding and fasting
and on standard diet and high-fat diet (Table 2). The
decrease was accompanied by signiﬁcantly lower insulin
levels (Table 2), except for the value for fasting while fed
on standard diet. After administration of glucose or insu-
lin, the difference in glucose levels between cGK-Tg and
wild-type mice became more prominent (Fig. 4D). Serum
triglyceride and fatty acid levels were similar for cGK-Tg
and wild-type mice, both during ad libitum feeding and
fasting, except for the signiﬁcant increase in fatty acid levels
in high-fat–fed cGK-Tg mice during fasting, when compared
with that of wild-type mice (Table 2). Urinary excretion of
the catecholamines (epinephrine and norepinephrine) was
similar for wild-type and cGK-Tg mice (Table 2).
In parallel with the reduction in body weight, fat tissues
assessed by means of CT analysis were signiﬁcantly reduced
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FIG. 1. Continued.
TABLE 1
Physical and metabolic parameters of high-fat–fed BNP-Tg mice
Wild type BNP-Tg
Body weight (g)
18 weeks old 43.0  0.9 38.9  0.9*
Glucose (mg/dl)
Ad libitum feeding 230.2  10.5 196.7  16.5†
24-h fasting 135.9  7.9 104.0  10.2†
Insulin (ng/dl)
Ad libitum feeding 9.87  1.9 5.25  1.1†
24-h fasting 1.05  0.2 0.86  0.1
Triglyceride (mg/dl)
Ad libitum feeding 131.9  13.2 126.7  15.6
24-h fasting 90.9  7.9 92.6  8.8
Fatty acid (mEq/l)
Ad libitum feeding 1.28  0.10 1.08  0.09
24-h fasting 1.70  0.17 1.75  0.21
Epinephrine (ng/day)
Urinary excretion 26.5  2.9 28.0  4.2
Norepinephrine (ng/day)
Urinary excretion 358.0  15.1 349.0  52.8
*P 	 0.01, †P 	 0.05, compared with wild type.
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Hematoxylin-eosin staining and the Coulter counter analysis
showed that the adipocytes in the epididymal fat were
smaller in cGK-Tg mice, with mean adipocyte diameters for
wild-type and cGK-Tg mice of 80 and 60 m, respectively,
when on standard diet (Fig. 4F and G). The high-fat diet
produced an increase in the diameter to 130 m in wild-type
mice but to only 80 m in the Tg mice (Fig. 4G). The liver of
high-fat–fed cGK-Tg mice weighed less than that of wild-type
mice (1.3  0.1 g and 1.8  0.1 g, n  8, P 	 0.01,
respectively) and had reddish appearance (Fig. 4H). The
hepatic triglyceride concentration of high-fat–fed cGK-Tg
mice was signiﬁcantly reduced when compared with wild-
type mice (30% decrease at 20 weeks, n  6, P 	 0.05) (Fig.
4I). Muscular triglyceride concentration of cGK-Tg mice was
also signiﬁcantly lower, even on standard diet, as well as in
high-fat–fed cGK-Tg mice (44% decrease in muscle triglycer-
ide at 20 weeks, n  6, P 	 0.01) (Fig. 4J).
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FIG. 2. High-fat–fed BNP-Tg mice exhibit higher oxygen consumption and fat oxidation in association with increased mitochondrial content in the
skeletal muscle. Mice were subjected to respiratory gas analysis after fed on high-fat diet. Total DNA and RNA were extracted from the brown
adipose tissue and the quadriceps, and quantitative PCR analysis was performed. A: Oxygen consumption on standard diet (left panel) and
high-fat diet (right panel)( n  6). u, wild type; f, BNP-Tg. B: Mean oxygen consumption for 24 h on standard diet or high-fat diet (n  6). C:
Rectal temperature on standard diet or high-fat diet (n  6). D: Respiratory quotient of high-fat–fed mice (n  6). u, wild type; f, BNP-Tg. E:
Mean fat oxidation estimated from the respiratory gas analysis for 24 h of high-fat–fed mice. F: Fat oxidation before and during fasting starting
from midnight. u, wild type; f, BNP-Tg. G: Mitochondrial DNA copy number estimated from quantiﬁcation of mitochondrial and nuclear genome
(n  8). H: Expressions of genes encoding PGC-1 and UCP1 in the brown adipose tissue and those for PGC-1 and PPAR in the skeletal muscle
(n  8). Standard diet: , wild type; o, BNP-Tg. High-fat diet: u, wild type; f, BNP-Tg. The values were standardized to those for the control
(wild-type [Wt] mice fed on standard diet) in either group. *P < 0.05; **P < 0.01 vs. wild type on the same feeding condition.
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etal muscle, associated with higher oxygen consump-
tion. The respiratory gas analysis demonstrated that the
oxygen consumption increased in the cGK-Tg mice, both
when on standard diet and on the high-fat diet (n  6, P 	
0.01) (Fig. 5A). Mean oxygen consumption for 24 h of
wild-type mice on standard diet was 63.5  0.3 ml  min
1 
kg body wt
1, and that of cGK-Tg was 71.7  0.4 ml 
min
1  kg body wt
1. The value of wild-type mice on
high-fat diet decreased to 43.6  0.2ml  min
1  kg body
wt
1, and that of cGK-Tg was 54.1  0.5 ml  min
1  kg
body wt
1 (Fig. 5B). The increase in oxygen consumption
in cGK-Tg mice was accompanied with a signiﬁcantly
higher rectal temperature (Fig. 5C). The respiratory quo-
tient showed a signiﬁcant reduction in cGK-Tg mice (n 
6, P 	 0.01) (Fig. 5D), and the reduction was prominent in
the light phase (data not shown), similar to the case of
BNP-Tg mice (Fig. 2D). Fat oxidation was increased in
cGK-Tg mice, both when on standard diet and on high-fat
diet (n  6, P 	 0.01) (Fig. 5E). Mean fat oxidation for 24 h
of high-fat–fed cGK-Tg mice was 22.8  0.5 ml  min
1  kg
body wt
1, and that of wild-type mice was 16.8  0.3 ml 
min
1  kg body wt
1.
Quantitative PCR analysis revealed increased mitochon-
drial DNA copy number in both the brown adipose tissue and
the skeletal muscle of cGK-Tg mice, both on standard and
high-fat diet (Fig. 5F). In conjunction with these ﬁndings, the
expressions of the genes encoding PGC-1 and UCP1 were
upregulated in the brown adipose tissue of cGK-Tg mice (Fig.
5G). In the skeletal muscle, expressions of the genes encod-
ing PGC-1 and PPAR were upregulated in cGK-Tg mice,
both when on standard and high-fat diet, associated with the
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FIG. 3. The expressions of NP receptors are regulated by feeding condition, while GCA knockdown mice are susceptible to diet-induced obesity
and glucose intolerance. Total RNA was extracted from the quadriceps of wild-type mice, and quantitative PCR analysis for the expressions of
NP receptors was performed. Wild-type and GCA heterozygous knockout mice (GCA
/) were given a high-fat (45 kcal% fat) diet from the age
of 8 weeks. A: Expressions of GCA, GCB, and C-receptor in the skeletal muscle, brown adipose tissue, and white adipose tissue of wild-type mice
for indicated feeding condition (n  8). The values represent the expression levels of each gene compared with that of -actin determined by
quantitative PCR analysis. Statistical analysis was performed to evaluate the effects of fasting and high-fat diet. *P < 0.05; **P < 0.01 vs. ad
libitum eating on the same diet. #P < 0.05; ##P < 0.01 vs. standard diet on the same eating condition (ad libitum or fasting). Further analysis to
clarify whether there were interactions between the effect of fasting and that of high-fat diet was performed as shown in supplemental Table S2.
u, skeletal muscle; f, brown adipose tissue; , white adipose tissue. B: Body weight of wild-type (Wt) and GCA
/ mice fed on standard diet
(dotted lines) or high-fat diet (solid lines) after 8 weeks of age (n  8). C: Food intake on high-fat diet (n  6). D: Blood glucose levels determined
with the glucose tolerance test (n  8). u, wild type; f, GCA
/. E: Total fat weight estimated from the CT images (n  6). *P < 0.05; **P < 0.01
vs. wild type on the same feeding condition. GCA
/, GCA heterozygous knockout mice.
K. MIYASHITA AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 58, DECEMBER 2009 2885Body weight
A
B
Standard chow
15
20
25
30
35
40
45
15
20
25
30
35
40
45
***
6 8 10 12 14 16 18
High-fat diet
High fat diet (60% fat)
6 8 10 12 14 16 18
**************
****
**********************
(Week) (Week)
(g)
E Total fat (g)
10
0
20
30
0
100
200
300
400
Blood glucose
(mg/dl) Glucose tolerance test (%basal)   Insulin tolerance test
(min) (min) 0 15 30 60 120 0 15 30 60 120
0
100
200
300
0
100
200
300
0
100
200
**
**
**
**
**
** ** **
* * * * * * * *
****
**
** ** High- fat diet High- fat diet
Standard chow Standard chow
D
Food intake
10
0
20
30 C
(kcal/day)
(kcal/day/g BW)
0.2
0
0.4 **
Wt cGK-Tg Wt cGK-Tg
High-fat diet Standard chow
Wt cGK-Tg
Wt cGK-Tg
High-fat diet
Standard chow
Wt cGK-Tg Wt cGK-Tg
High-fat diet Standard chow
FIG. 4. cGK-Tg mice are lean and insulin sensitive even on standard diet. Wild-type and cGK-Tg mice were given a high-fat (60 kcal% fat) diet from the
age of 10 weeks. A: Body weight of cGK-Tg mice on standard diet (left panel) and high-fat diet (right panel)( n  8–10). u, wild type; f, cGK-Tg. B:
Macroscopic appearance of a wild-type (Wt) and a cGK-Tg mouse. C: Food intake on standard and high-fat diet (upper panel) (kcal/day, n  6) and the
body weight (BW)-adjusted value (lower panel) (kcal  day
1  g body wt
1). D: Blood glucose levels determined with the glucose and insulin tolerance
tests for each genotype on standard diet and high-fat diet (n  8). u, wild type; f, cGK-Tg. E: CT images obtained at kidney level of a wild-type (Wt)
and a cGK-Tg mouse on standard diet (upper panel) and high-fat diet (lower panel). Subcutaneous fat (yellow), abdominal fat (red), and muscular
region (blue) were distinguished. Total fat weight was estimated from the images (n  6). F: Microscopic analysis using hematoxylin and eosin staining
of epididymal fats in high-fat–fed mice. Scale bar, 100 m. G: Distribution of adipocyte diameter determined with Coulter counter (n  8). u, wild type;
f, cGK-Tg. H: Macroscopic appearance of the liver in high-fat–fed mice (upper panel). Microscopic images with Oil red O staining of the liver (lower
panel). Scale bar, 100 m. I and J: Triglyceride concentration in the liver (I) and the quadriceps (J)( n  12). *P < 0.05; **P < 0.01 vs. wild type on
the same feeding condition. (A high-quality color digital representation of this ﬁgure is available in the online issue.)
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chondrial oxidative function and fatty acid catabolism (Fig.
5H). In addition to PGC-1 and PPAR, the expression of
ATP synthase (ATPsyn), cythochrome c oxidase (COX), and
carnitine palmitoyl transferase (CPT) 1b was signiﬁcantly
enhanced in the skeletal muscle of cGK-Tg mice, compared
with wild-type mice, both when on standard diet and high-fat
diet; while UCP3, fatty acid transporter (FATP), and acyl-
CoA oxidase (ACO) were upregulated when on the high-fat
diet only (Fig. 5H). The expression of PPAR in the skeletal
muscle of cGK-Tg mice was not signiﬁcantly different from
wild-type mice, although high-fat diet increased the expres-
sion (data not shown). Giant mitochondria were densely
packed in the skeletal muscle of high-fat–fed cGK-Tg mice
when it was observed by means of an electron microscope
(Fig. 5I).
NPs directly increase the expression of PGC-1 and
PPAR and mitochondrial content in cultured myo-
cytes. The results of the study shown in Fig. 6A and B are
described in supplement 2. Schematic representation of
the suggested roles for NP/cGK cascades, as described in
the present and previous studies, is shown in Fig. 6C.
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FIG. 4. Continued.
TABLE 2
Physical and metabolic parameters of cGK-Tg mice fed on standard chow or high-fat diet
Standard chow High-fat diet
Wild type cGK-Tg Wild type cGK-Tg
Body weight (g)
18 weeks old 32.0  0.6 27.6  0.4* 43.9  1.2 35.7  1.4*
Glucose (mg/dl)
Ad libitum feeding 160.7  6.0 137.7  5.1* 233.5  17.1 174.0  7.7*
24-h fasting 93.5  4.7 78.8  2.3† 113.5  7.6 89.8  3.7†
Insulin (ng/dl)
Ad libitum feeding 1.4  0.2 0.8  0.2† 9.1  1.0 3.5  0.6*
24-h fasting 0.26  0.05 0.23  0.03 0.95  0.22 0.41  0.05†
Triglyceride (mg/dl)
Ad libitum feeding 103.3  10.1 89.2  7.0 134.9  11.5 134.9  15.8
24-h fasting 84.3  6.8 81.6  6.9 112.8  9.5 103.4  11.6
Fatty acid (mEq/l)
Ad libitum feeding 1.04  0.05 0.84  0.10 1.32  0.18 1.08  0.11
24-h fasting 1.69  0.09 1.86  0.08 1.66  0.09 2.22  0.08*
Epinephrine (ng/day)
Urinary excretion 48.2  9.3 52.7  12.8 49.6  6.3 40.5  6.1
Norepinephrine (ng/day)
Urinary excretion 312.3  62.2 312.3  97.4 547.7  62.2 570.3  47.6
*P 	 0.01, †P 	 0.05 compared with wild type on the same feeding condition.
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The ﬁndings in this study demonstrate that the activation
of NP/cGK cascades augments mitochondrial biogenesis
and fat oxidation in mice through upregulation of PGC-1
and PPAR in the skeletal muscle, thus conferring resis-
tance to obesity and glucose intolerance. BNP-Tg mice fed
a high-fat diet were protected from obesity and insulin
resistance, while cGK-Tg mice were lean even on standard
diet and showed increased insulin sensitivity, and, surpris-
ingly, giant mitochondria were densely packed in the
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FIG. 5. cGK-Tg mice exhibit giant mitochondria in the skeletal muscle, associated with higher oxygen consumption and fat oxidation. Mice were
subjected to respiratory gas analysis after fed on high-fat diet. Total DNA and RNA were extracted from the brown adipose tissue and the
quadriceps, and quantitative PCR analysis was performed. A: Oxygen consumption on standard diet (n  6). u, wild type; f, cGK-Tg. B: Mean
oxygen consumption for 24 h on standard or high-fat diet. C: Rectal temperature on standard or high-fat diet (n  12). D: Mean respiratory
quotient for 24 h on standard or high-fat diet (n  6). E: Mean fat oxidation estimated from the respiratory gas analysis for 24 h on standard or
high-fat diet (n  6). F: Mitochondrial DNA copy number estimated from quantiﬁcation of mitochondrial and nuclear genome (n  8). G:
Expressions of genes encoding PGC-1 and UCP1 in the brown adipose tissue. The values were standardized to those for the control (wild-type
[Wt] mice fed on standard diet) in either group (n  12). H: Expressions of the genes involved in mitochondrial regulation or fatty acid catabolism
in the skeletal muscle (n  12). Standard diet: , wild type (control); o, cGK-Tg. High-fat diet: u, wild type; f, cGK-Tg. I: Electron microscopic
analysis of muscle mitochondria of high-fat–fed cGK-Tg mice. *P < 0.05; **P < 0.01 vs. wild-type mice on the same feeding condition.
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fat tissue and excessive lipid accumulation in the liver and
skeletal muscle, in accordance with an increase in fat
oxidation. Functional NP receptors were upregulated dur-
ing fasting, whereas they were downregulated by ad
libitum feeding or high-fat challenge, while whole-body
knockdown of the functional receptor, GCA, led to pro-
motion of obesity in mice. These ﬁndings, together with
those that demonstrated NP-induced lipolysis, lead us to
propose the concept that NP/cGK cascades play signiﬁcant
roles in lipid catabolism during fasting or chronic caloric
restriction, in addition to their well-known roles in the
cardiovascular system, such as in the attenuation of hy-
pertension and congestive heart failure (Fig. 6C) (7,8,17).
Genetic overexpression of NP/cGK in mice attenuated
diet-induced obesity and insulin resistance, associated
with the increase in muscle mitochondrial content and fat
oxidation. We identiﬁed the dual upregulation of PGC-1
and PPAR in the skeletal muscle of the Tg mice as a
molecular basis of the increase in mitochondria and
conﬁrmed the direct increase in the expression of PGC-1
and PPAR and mitochondrial content by both ANP and
BNP through the experiments using cultured myocytes.
PGC-1 is a transcriptional cofactor that acts as a master
regulator of mitochondrial biogenesis (18). PPAR is a
transcription factor that binds with PGC-1 and enhances
mitochondrial biogenesis and lipid catabolism (19). Acti-
vation of PPAR in mice by the treatment with the PPAR
agonist GW501516 or overexpression of a constitutively
active form of PPAR were shown to increase muscle
mitochondrial content and fatty acid oxidation and, thus,
prevent diet-induced obesity and glucose intolerance
(20,21). However, mice with muscle-speciﬁc overexpres-
sion of wild-type PPAR did not exhibit such a prominent
phenotype (22). Muscle-speciﬁc overexpression of PGC-1
has been reported to not prevent diet-induced obesity and
insulin resistance in mice, although there was an increase
in mitochondrial content (23). These results indicate that
the coordinated increase in the expression of PGC-1 and
PPAR, which was observed in the skeletal muscle of
BNP- and cGK-Tg mice, led to synergistic effects that were
beneﬁcial for ameliorating diet-induced obesity and insulin
resistance. The expression of PGC-1 and PPAR in
muscle is augmented by exercise via exercise-sensitive
molecules such as AMP-activated protein kinase (AMPK)
(18,19). The increases in circulating NP and cGMP levels
during exercise have been demonstrated in previous re-
ports (24,25). Therefore, we hypothesize that NP/cGMP/
cGK cascades can interact with the exercise-sensitive
molecules in muscle and increase the expression of
PGC-1 and PPAR.
BNP-Tg mice gained less body weight than controls
when they were fed on high-fat diet. The same tendency
was observed even when on standard diet; however, the
magnitude of the change was not so prominent. We
interpret the results as the Tg mice escaped from diet-
induced obesity by increasing muscle mitochondrial con-
tent and fat oxidation. The elevation of serum adiponectin
levels observed in the high-fat–fed BNP-Tg mice, associ-
ated with reduced adiposity, might be contributing to the
attenuation of insulin resistance (26,27). Apparent changes
in food intake and catecholamine kinetics were not ob-
served.
In cGK-Tg mice, the increase in mitochondria was
evident even on standard diet, resulting in the Tg mice
being leaner and more insulin sensitive than BNP-Tg mice.
Our data suggested that one reason for the difference in
the magnitude of the altered phenotypes between the
BNP- and cGK-Tg mice was caused by the variations of the
target tissues. In the skeletal muscle, similar changes in
gene expression were evident in the two lines of Tg mice,
including upregulation of PGC-1 and PPAR. In the
brown adipose tissue, on the other hand, the increase in
the expression level of PGC-1 and its downstream effec-
tor UCP1 was signiﬁcant in cGK-Tg mice, associated with
higher body temperature; however, these changes were
not so prominent in BNP-Tg mice. We observed that the
functional receptors for NP, GCA, and GCB were abun-
dantly expressed in the brown adipose tissue; however,
the clearance receptor (C-receptor) was also rich in the
tissue. Therefore, the functional receptor–to–C-receptor
ratio, which is suggested to correlate with the biological
action of NPs, was lower in the brown adipose tissue than
skeletal muscle. We speculate that the abundant expres-
sion of C-receptor and the lower ratio of the functional
receptors reduced the effect of NP in the brown adipose
tissue.
High-fat–fed GCA heterozygous knockout mice accumu-
lated more fat mass and were glucose intolerant compared
with wild-type mice. This phenotype is the opposite to that
of BNP-Tg or cGK-Tg mice so that the effects of NPs in
terms of the prevention of diet-induced obesity and insulin
resistance seemed to be mediated at least in part by GCA.
We were unable to determine whether GCB also partici-
pated because GCB knockout mice were not available.
The NP receptors were regulated by dietary conditions;
that is, GCA and GCB were upregulated by fasting and
downregulated during high-fat feeding. On the other hand,
the C-receptor showed opposite kinetics. Therefore, the
ratio of functional receptors to C-receptor was lowered by
feeding or during chronic high-fat diet; conversely, fasting
increased relative amount of the functional receptors.
These results indicate that a high-fat diet can contribute to
the development of diet-induced obesity and insulin resis-
tance at least partly by downregulation of GCA and
upregulation of the C-receptor. The notion that the kinet-
ics of NP receptor expression depend on dietary condi-
tions, such as high-fat diet or fasting, is consistent with
earlier ﬁndings of others. The GCA–to–C-receptor ratio
was shown to be lowered in obese people than in nono-
bese (28). Natriuresis is known to be increased after
several hours of fasting, despite the fact that sodium
intake is decreased (29). The upregulation of functional
NP receptors in renal tubular cells by fasting and subse-
quent augmentation of natriuresis might account for the
I
Wt cGK-Tg
FIG. 5. Continued.
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Taken together, the dietary regulation of the receptor
expressions indicates that the signal transduction through
NP/cGK cascades, which is augmented by starvation,
might have a role in fasting-induced fat oxidation under
physiological conditions.
Augmented production of NPs caused by congestive
heart failure plays important roles in compensating for the
volume expansion and subsequent decrease in oxygen sup-
plybyexertingvasodilating,natriuretic,andneurohumoral-
modulating actions (30). This compensatory effect in the
cardiovascular system has been thought to be the primary
role for NP/cGK cascades (31). In the present study, we
reveal the new roles for the cascades on mitochondrial
biogenesis and fat oxidation through upregulation of
PGC-1 and PPAR. The results of the present study are in
line with earlier publications from Lafontan and col-
leagues (6,7,32,33), which have demonstrated the impor-
tance of the NP/cGK system in the regulation of adipose
tissue lipolysis. Their results and ours together support the
view that NP/cGK cascades have signiﬁcant roles in lipid
catabolism. Moreover, the increase in circulating NP and
cGMP levels during exercise has been demonstrated in
previous reports (24,25). Therefore, NP/cGMP/cGK cas-
cades might have signiﬁcant roles in metabolic adapta-
tions in response to exercise, including mitochondrial
biogenesis and fat oxidation.
Several other vascular hormones that regulate vascular
tone, including catecholamines, angiotensin II, and NO,
are also implicated in the regulation of cellular metabolism
and subsequent change in body weight and glucose toler-
ance (34–38). In this context, vascular hormones seem to
lie at the crossroad of cardiovascular and metabolic
diseases. In a recent report (9), the number of risk factors
acting as diagnostic markers of metabolic syndrome is
shown to inversely correlate with plasma concentrations
of NPs. The clinical data and the ﬁndings of the present
study collectively indicate that insufﬁcient activation of
NP/cGK cascades can be a causative factor of both obesity
and hypertension. We speculate that the state of overnu-
trition would downregulate functional NP receptors as to
promote both obesity and hypertension. Furthermore, we
believe that physiological responses of vascular hor-
mones, in accordance with blood pressure, circulating
ﬂuid volume, and oxygen demand, would result in coordi-
nated regulation of oxygen supply and consumption, and
the coordination is especially important for the adaptive
responses to exercise.
To summarize, the results of the present study indicate
that NP/cGK cascades can promote muscle mitochondrial
biogenesis and fat oxidation through upregulation of
PGC-1 and PPAR, as to prevent obesity and glucose
intolerance. The results were compatible with our recent
report (10), which showed that cGMP can increase mito-
chondrial content and function in cultured myocytes. The
pharmaceutical interventions that activate NP/cGMP/cGK
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FIG. 6. NPs directly increase the expression of PGC-1 and PPAR and
mitochondrial content in cultured myocytes. C2C12 myocytes were
stimulated with the indicated agents for 8 (A)o r4 8( B) hours (ANP
10
119 mol/l or BNP 10
119 mol/l, with or without the cGMP
antagonist, Rp-8-br-cGMP [Rp] 10
4 mol/l). Stimulation of cGK by
8-Br-cGMP (cG) 10
4 mol/l was also challenged (n  12). A: Gene
expressions of PGC-1 and PPAR in C2C12 cells when treated with
ANPs or BNPs. B: Mitochondrial mass in C2C12 cells quantiﬁed by use
of MitoTracker Green, a ﬂuorescent probe for mitochondria. *P < 0.05;
**P < 0.01 vs. control; #P < 0.05; ##P < 0.01 vs. the NP (10
9
mol/l)-treated group. Rp, Rp-8-br-cGMP (cGMP antagonist), cG, 8-Br-
cGMP (membrane-permeable cGMP analog). C: Schematic representa-
tion of the suggested roles for NP/cGK cascades. Previous studies have
shown the signiﬁcant roles for NP/cGK cascades in the cardiovascular
system that lead to resistance to ischemia, heart failure, and hyperten-
sion. In the present study, NP/cGK cascades are suggested to promote
muscle mitochondrial biogenesis and fat oxidation, as to prevent
obesity, fatty liver, and glucose intolerance.
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ment of obesity, fatty liver, and glucose intolerance.
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